GO:0071735 IgG immunoglobulin complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071735 describes the IgG immunoglobulin complex, a heterotetramer of two identical IgG heavy chains and two identical light chains held together by disulfide bonds.
• IgG complexes can be membrane-embedded (B-cell receptor) or secreted into blood, lymph, mucosal areas, and other tissues.
• The complex is central to humoral immunity, Fc receptor engagement, and therapeutic antibody function.
• IgG subclasses (IgG1, IgG2, IgG2a, IgG2b, IgG2c, IgG3, IgG4) differ in structure and effector function.
• Dysregulated IgG complexes contribute to autoimmune diseases such as immune thrombocytopenia and atherosclerosis.
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of IgG complex biology.
Description
The IgG immunoglobulin complex (GO:0071735) is a protein complex composed of two identical immunoglobulin heavy chains of an IgG isotype and two identical immunoglobulin light chains, held together by disulfide bonds. This complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph. As the predominant antibody class in serum, IgG complexes are fundamental to humoral immunity and are the basis for most therapeutic monoclonal antibodies. Researchers study GO:0071735 to understand antibody assembly, Fc receptor interactions, and the mechanisms of autoimmune and inflammatory diseases. The term encompasses multiple subclasses, including IgG1, IgG2, IgG2a, IgG2b, IgG2c, IgG3, and IgG4, which differ in their effector functions and clinical relevance. Because IgG complexes are both diagnostic markers and therapeutic agents, precise models of their structure and regulation are essential for translational research.
IgG immunoglobulin complex At A Glance
| GO ID | GO:0071735 |
|---|---|
| GO term | IgG immunoglobulin complex |
| Ontology | cellular_component |
| Synonym | IgG1, IgG2, IgG2a, IgG2b, IgG2c, IgG3, IgG4 |
| Major function | Antigen recognition and Fc-mediated effector functions in humoral immunity |
| Subunit composition | Two identical IgG heavy chains and two identical light chains |
| Assembly | Disulfide bond-mediated heterotetramerization |
| Localization | Plasma membrane, extracellular space, mucosal areas, blood, lymph |
| Fc receptors | Interacts with Fc gamma receptors on immune cells |
What Is GO:0071735?
GO:0071735 defines the IgG immunoglobulin complex as a heterotetrameric protein complex consisting of two identical IgG heavy chains and two identical light chains, covalently linked by disulfide bonds. The complex can exist in a membrane-bound form, such as the B-cell receptor, or as a secreted molecule in extracellular fluids including blood, lymph, and mucosal secretions. This definition captures the canonical Y-shaped antibody architecture and its diverse physiological contexts.
Why Is IgG immunoglobulin complex Important in Cell Biology?
The IgG immunoglobulin complex is essential for adaptive immunity, as it neutralizes pathogens, activates complement, and mediates antibody-dependent cellular cytotoxicity through Fc receptors. Its structural and functional diversity across subclasses underpins the efficacy of therapeutic antibodies and vaccines. Dysregulated IgG complexes are directly implicated in autoimmune diseases, including immune thrombocytopenia and atherosclerosis, making them critical targets for clinical intervention. Understanding GO:0071735 at the molecular level informs the design of engineered antibodies and CRISPR-based models for disease research.
• IgG complexes are the primary mediators of humoral immunity against pathogens.
• They serve as the B-cell receptor for antigen recognition on B lymphocytes.
• Fc receptor engagement by IgG complexes triggers phagocytosis and cytokine release.
• Therapeutic monoclonal antibodies are engineered IgG complexes.
• IgG subclasses exhibit distinct effector functions and clinical applications.
• Autoantibody IgG complexes drive immune thrombocytopenia.
• IgG deposition contributes to atherosclerosis and cardiovascular disease.
• IgG complexes are biomarkers for autoimmune and infectious diseases.
• CRISPR models of IgG genes enable functional dissection of antibody responses.
• IgG-FcRn interactions regulate antibody half-life and transcytosis.
What Happens During IgG immunoglobulin complex?
Heavy and Light Chain Synthesis
In simple terms: The cell first builds the protein chains that will become the antibody.
IgG heavy and light chains are synthesized and translocated into the endoplasmic reticulum, where they fold and assemble into the heterotetrameric complex. This process is coordinated with quality control mechanisms to ensure only properly folded complexes are secreted.
Disulfide Bond Formation and Assembly
In simple terms: The chains are stapled together by chemical bonds to form the Y-shaped antibody.
Disulfide bonds between heavy chains and between heavy and light chains stabilize the IgG complex. The assembly of two heavy chains and two light chains yields the canonical Y-shaped structure with two antigen-binding Fab arms and an Fc region.
Membrane vs. Secreted Forms
In simple terms: The same complex can either stay on the cell surface or be released into the blood.
Membrane-bound IgG complexes function as B-cell receptors, while secreted forms circulate in blood, lymph, and mucosal areas. Alternative splicing of heavy chain transcripts determines whether the complex is membrane-anchored or secreted.
Fc Receptor Engagement
In simple terms: Once released, the antibody binds to receptors on immune cells to trigger responses.
Secreted IgG complexes bind Fc gamma receptors on macrophages, neutrophils, and natural killer cells, initiating effector functions such as phagocytosis and antibody-dependent cellular cytotoxicity. The Fc region also interacts with the neonatal Fc receptor (FcRn) to regulate half-life and transcytosis.
Key Genes Involved in GO:0071735 IgG immunoglobulin complex
The following genes and proteins are central to the structure, assembly, and function of the IgG immunoglobulin complex.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IGHG1 | Encodes IgG1 heavy chain constant region | Most abundant subclass; therapeutic antibody backbone |
| IGHG2 | Encodes IgG2 heavy chain constant region | Associated with polysaccharide antigen responses |
| IGHG3 | Encodes IgG3 heavy chain constant region | Potent complement activation |
| IGHG4 | Encodes IgG4 heavy chain constant region | Non-inflammatory; used in blocking antibodies |
| IGKC | Encodes kappa light chain constant region | Light chain component of IgG complex |
| IGLC1 | Encodes lambda light chain constant region | Alternative light chain for IgG assembly |
| FCGR1A | High-affinity Fc gamma receptor I | Mediates IgG effector functions |
| FCGR2A | Fc gamma receptor IIa | Involved in phagocytosis and immune complex clearance |
| FCGR3A | Fc gamma receptor IIIa | Mediates antibody-dependent cellular cytotoxicity |
| FCGRT | Neonatal Fc receptor (FcRn) heavy chain | Regulates IgG half-life and transport |
| B2M | Beta-2-microglobulin | Associated with FcRn-mediated IgG recycling |
| C1Q | Complement component 1q | Binds IgG complexes to initiate classical complement pathway |
| PRDM1 | Blimp-1 transcription factor | Regulates plasma cell differentiation and IgG secretion |
| XBP1 | X-box binding protein 1 | Controls secretory capacity for IgG production |
| IRF4 | Interferon regulatory factor 4 | Required for plasma cell IgG synthesis |
| AICDA | Activation-induced cytidine deaminase | Class switch recombination to IgG isotypes |
| IGHM | IgM heavy chain | Precursor for class switching to IgG |
How Is IgG immunoglobulin complex Regulated?
The expression and assembly of IgG immunoglobulin complexes are regulated at multiple levels. Class switch recombination, mediated by activation-induced cytidine deaminase (AICDA), determines the IgG subclass. Transcription factors such as PRDM1, XBP1, and IRF4 coordinate plasma cell differentiation and secretory capacity. Fc receptor expression and signaling modulate the effector functions of secreted IgG complexes. Additionally, the neonatal Fc receptor (FcRn) regulates IgG half-life and transcytosis, influencing serum IgG levels.
IgG immunoglobulin complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| FCGR2A | Immune thrombocytopenia | Knockout mouse or iPSC-derived macrophages |
| IGHG1 | Atherosclerosis | ApoE-/- mouse with IgG1 overexpression |
| FCGRT | IgG half-life disorders | FcRn knockout mouse |
| AICDA | Hyper-IgM syndrome | AICDA knockout B cells |
| C1Q | Systemic lupus erythematosus | C1q knockout mouse |
Autoimmune Diseases
IgG autoantibodies form immune complexes that drive tissue damage in autoimmune conditions. In immune thrombocytopenia, platelet-reactive IgG antibodies mediate platelet destruction. Intravenous immunoglobulin therapy is used to neutralize pathogenic IgG complexes and modulate Fc receptor activity.
Atherosclerosis
IgG complexes deposited in arterial walls contribute to inflammation and plaque formation. Elevated levels of IgG against oxidized LDL are associated with atherosclerosis progression. Therapeutic modulation of IgG complexes is being explored for cardiovascular protection.
Fungal Immunity and Microbiota
IgG complexes play a role in anti-fungal immunity at mucosal surfaces, interacting with the gut mycobiota. These interactions influence host defense and immune homeostasis.
From IgG immunoglobulin complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does IgG subclass affect Fc receptor binding? | Point-mutation knock-in of heavy chain constant regions |
| What is the role of FcRn in IgG half-life? | FCGRT knockout mouse |
| How does IgG complex assembly occur? | Tagged knock-in of IGHG1 for live-cell imaging |
| Can IgG overexpression drive autoimmunity? | Transgenic overexpression of IgG heavy chains |
| What genes regulate plasma cell IgG secretion? | CRISPR knockout screen in B cells |
| How do IgG complexes interact with mycobiota? | Gnotobiotic mouse models with IgG knockout |
How to Study the IgG immunoglobulin complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | High-resolution structure of IgG complexes | Antibody engineering |
| Mass spectrometry | IgG complex composition and modifications | Proteomic profiling |
| Flow cytometry | Surface IgG expression | B-cell phenotyping |
| Immunoprecipitation | Protein-protein interactions | Fc receptor binding studies |
| CRISPR knockout screen | Gene essentiality for IgG production | Target discovery |
| ELISA | IgG concentration in serum | Autoantibody detection |
| Confocal microscopy | Subcellular localization | Imaging IgG trafficking |
Structural Biology
X-ray crystallography and cryo-electron microscopy reveal the atomic structure of IgG complexes and their interactions with Fc receptors. These methods are essential for understanding subclass-specific differences and engineering therapeutic antibodies.
Proteomics and Immunoprecipitation
Mass spectrometry-based proteomics and immunoprecipitation identify IgG complex components and post-translational modifications. Protein G-gold labeling enables ultrastructural localization of IgG complexes in tissues.
Flow Cytometry and Imaging
Flow cytometry quantifies membrane-bound IgG complexes on B cells, while confocal microscopy visualizes their localization. These techniques are used to study Fc receptor engagement and internalization.
CRISPR Screening
Genome-wide CRISPR knockout screens identify regulators of IgG secretion and class switching in B cells. These screens are powerful for discovering novel therapeutic targets in autoimmunity.
How CRISPR Can Be Used to Study GO:0071735 IgG immunoglobulin complex
Knockout
CRISPR knockout of IgG heavy or light chain genes abolishes IgG complex formation, enabling loss-of-function studies in B cells and plasma cells. Knockout of Fc receptors clarifies their specific roles in IgG-mediated effector functions.
Point Mutation
Point mutations in IgG constant regions can alter Fc receptor binding and complement activation, allowing precise structure-function analysis. These models are valuable for engineering antibodies with tailored effector profiles.
Knock-in
Knock-in of tagged IgG heavy chains enables live-cell imaging and tracking of IgG complex assembly and secretion. Knock-in of human IgG genes into mouse models facilitates translational studies.
Overexpression
Overexpression of IgG heavy and light chains in cell lines produces recombinant antibodies for therapeutic and diagnostic applications. Overexpression models also help study the consequences of IgG excess in autoimmunity.
How EDITGENE Supports IgG immunoglobulin complex Research
Researchers studying IgG immunoglobulin complex-related genes often need to determine whether a candidate gene is causally involved in antibody assembly, secretion, or effector function. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for IgG immunoglobulin complex research.
Frequently Asked Questions About IgG immunoglobulin complex
What is GO:0071735?
GO:0071735 is the Gene Ontology term for the IgG immunoglobulin complex, a heterotetramer of two IgG heavy chains and two light chains held by disulfide bonds.
What genes are involved in IgG immunoglobulin complex?
Key genes include IGHG1, IGHG2, IGHG3, IGHG4, IGKC, IGLC1, and Fc receptor genes such as FCGR1A, FCGR2A, FCGR3A, and FCGRT.
Where is the IgG immunoglobulin complex located?
It can be embedded in the plasma membrane or present in extracellular space, mucosal areas, blood, or lymph.
What are the synonyms for GO:0071735?
Synonyms include IgG1, IgG2, IgG2a, IgG2b, IgG2c, IgG3, and IgG4.
How is the IgG immunoglobulin complex assembled?
Two heavy chains and two light chains assemble in the endoplasmic reticulum, stabilized by disulfide bonds.
What diseases involve IgG immunoglobulin complexes?
Autoimmune diseases such as immune thrombocytopenia and atherosclerosis involve pathogenic IgG complexes.
How do Fc receptors interact with IgG complexes?
Fc gamma receptors on immune cells bind the Fc region of IgG, triggering phagocytosis and cytokine release.
What is the role of FcRn in IgG biology?
The neonatal Fc receptor (FcRn) regulates IgG half-life and transcytosis across cellular barriers.
How can CRISPR be used to study IgG complexes?
CRISPR knockout, knock-in, and overexpression models enable functional dissection of IgG genes and regulators.
What methods are used to study IgG immunoglobulin complexes?
Methods include cryo-EM, mass spectrometry, flow cytometry, immunoprecipitation, and CRISPR screens.
Conclusion
The IgG immunoglobulin complex (GO:0071735) is a central component of humoral immunity, with critical roles in pathogen neutralization, autoimmunity, and therapeutic antibody function. Understanding its assembly, regulation, and interactions with Fc receptors provides a foundation for developing targeted therapies. CRISPR-based models and advanced structural techniques continue to illuminate the biology of this complex, offering new avenues for disease intervention.
References
- 1. Eibl MM et al.. 1989. Intravenous immunoglobulin: a review.. Immunodefic Rev 1 Suppl:1-42 PMID: 2698646
- 2. Taatjes DJ et al.. 1987. Streptococcal protein G-gold complex: comparison with staphylococcal protein A-gold complex for spot blotting and immunolabeling.. Eur J Cell Biol 45(1):151-9 PMID: 3327693
- 3. Doron I et al.. 2023. Immunoglobulins at the interface of the gut mycobiota and anti-fungal immunity.. Semin Immunol 67:101757 PMID: 37003056
- 4. Hegde UM. 1992. Platelet antibodies in immune thrombocytopenia.. Blood Rev 6(1):34-42 PMID: 1586777
- 5. Matsuura E et al.. 2005. Intravenous immunoglobulin and atherosclerosis.. Clin Rev Allergy Immunol 29(3):311-9 PMID: 16391407
- 6. Raghavan M et al.. 1996. Fc receptors and their interactions with immunoglobulins.. Annu Rev Cell Dev Biol 12:181-220 PMID: 8970726
- 8. Deng M et al.. 2026. Structure of the IgY-FcRY complex and its comparison with IgG-FcRn.. Structure 34(6):893-900.e3 PMID: 42086046
